EndoStim™ LES Stimulation Therapy for Gastro-esophageal Reflux Disease (GERD) Receives CE Mark

by admin on August 17, 2012

THE HAGUE, Netherlands, Aug. 16, 2012 /PRNewswire/ — EndoStim B.V. voiced currently CE Mark capitulation of the LES Stimulation System for the diagnosis of gastro-esophageal reflux mildew (GERD). 

(Logo: http://photos.prnewswire.com/prnh/20120816/CG58802LOGO)

The EndoStim complement uses low appetite electrical pulses to make firm the diseased or dysfunctional revoke esophageal sphincter (LES) flesh which is the underlying means of gastro-esophageal reflux disease (GERD) or poison reflux. EndoStim’s device, ingrained by the minimally-invasive laparoscopic procedure, is dictated to provide poison reflux as well as eliminate the need for every day PPI medication. In clinical trials the diagnosis was means to significantly revoke poison bearing as well as associated symptoms of heartburn as well as regurgitation without causing any gastrointestinal side effects seen with alternative anti-reflux procedures.

Bevil Hogg, President as well as CEO of EndoStim, stated, “EndoStim is really vehement to suggest the indeed insubordinate diagnosis to patients with severe GERD — the single which is written to normalize esophageal function.  EndoStim is operative closely with heading GERD experts via the universe to rise ‘Centers of Excellence’ charity EndoStim diagnosis for the millions of GERD sufferers worldwide.”

Virender K Sharma MD, Chief Medical Officer of EndoStim as well as Director of the Arizona Center for Digestive Health, adds, “EndoStim LES kick care is the outcome of years of investigate as well as growth with heading researchers in esophageal diseases in the US as well as clinical investigators in Europe as well as South America. EndoStim’s long-term clinical interpretation strongly supports the efficiency as well as reserve of the care in patients with serious GERD.”

Clinical formula from the CE study denote thespian alleviation of poison reflux whilst permitting for normal esophageal function, such as swallowing as well as belching.  The interpretation prove which 100% of patients who perceived EndoStim diagnosis for twelve months were means to stop every day PPI use as well as 77% completed normalization or larger than 50% rebate in aberrant esophageal poison exposure.

EndoStim LES kick care has shown both daytime as well as nighttime alleviation in heartburn symptoms as well as regurgitation. The diagnosis is additionally singular in the capability to be personalized to particular studious lifestyle, diet as well as preferences.  According to Dr. Joel Richter, Professor of Medicine as well as Director of the Division of Digestive Diseases as well as Nutrition during the University of South Florida, “What separates EndoStim LES kick record from all prior GERD technologies is the capability to scold GERD pathophysiology as well as normalize or urge esophageal poison exposure. Safety as well as miss of side goods with this record creates it an tasteful choice for patients seeking for alternatives to normal healing therapy.”

Dr. Leonardo Rodriguez, the lead questioner for the CE Mark hearing conducted in Santiago, Chile, says, “I hold which EndoStim LES kick therapy is the ideal diagnosis choice for patients with serious GERD who have been unfortunate with their healing care or wish leisure from life-long coherence upon medications.  I am really tender with the clinical formula as well as demeanour brazen to charity EndoStim care to my GERD patients.”

EndoStim is stability trials in pass centers opposite South America, Europe, as well as Asia.  Prof. Peter D Siersema, Professor of Medicine, Director of Gastroenterology during University Medical Center, Utrecht, The Netherlands as well as the principal questioner in the ongoing EndoStim general multicenter hearing commented that, “We have been vehement to be between the initial sites in Europe to suggest the EndoStim LES kick care to the patients. The EndoStim technology has the intensity to shift the approach you conduct GERD. With the capability to personalize treatment to an particular patient’s condition, as well as with the glorious reserve profile, EndoStim care could turn the preferred choice for reflux patients payable or unfortunate with every day medications.”

EndoStim has started enrolling the blurb registry investigate worldwide as well as is formulation for the US investigate to proceed in late 2013.

About Reflux Disease
Gastroesophageal reflux mildew is the ongoing mildew which affects hundreds of millions of patients worldwide, as well as mostly requires lifelong diagnosis with poison blocker medications. Symptoms in all start when the debility in the revoke esophageal sphincter flesh allows go through essence to upsurge back in to the esophagus causing esophageal exasperation as well as damage. Acid reflux causes heartburn, regurgitation as well as can lead to Barrett esophagus as well as esophageal cancer. Millions of people go upon to humour from troublesome GERD symptoms notwithstanding maximal healing therapy.

About EndoStim
EndoStim is the venture-backed healing device association formed in The Hague, The Netherlands, as well as St. Louis, Missouri, focused upon building innovative active implantable devices. Key investors embody Santé Ventures (Austin, TX), Prolog Ventures (St. Louis, MO), Voyent Partners (Brentwood, TN) as well as Vectis Healthcare Life Sciences Fund II (St. Louis, MO), along with most particular investors.  For some-more report as well as headlines about EndoStim, greatfully revisit www.endostim.com.

Contact:
Eileen Ke
314-615-6346
eke@endostim.com

Comments on this entry are closed.

Previous post:

Next post: